Astera Labs (NASDAQ:ALAB) Stock Price Down 4.7% – Time to Sell?
by Amy Steele · The Cerbat GemAstera Labs, Inc. (NASDAQ:ALAB – Get Free Report)’s stock price fell 4.7% on Thursday . The stock traded as low as $163.75 and last traded at $163.9260. 551,262 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 5,201,073 shares. The stock had previously closed at $172.09.
Wall Street Analyst Weigh In
Several research firms have weighed in on ALAB. Royal Bank Of Canada began coverage on Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target on the stock. Loop Capital began coverage on Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target on the stock. Weiss Ratings cut Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Barclays set a $165.00 price target on Astera Labs in a report on Thursday, January 15th. Finally, Citigroup began coverage on Astera Labs in a report on Thursday, April 2nd. They issued a “buy” rating and a $200.00 price target on the stock. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $199.44.
Check Out Our Latest Analysis on ALAB
Astera Labs Trading Down 2.6%
The company has a market capitalization of $28.70 billion, a PE ratio of 137.30, a PEG ratio of 3.36 and a beta of 1.78. The stock has a fifty day moving average of $129.19 and a two-hundred day moving average of $154.42.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The company had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same period last year, the firm posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.
Insider Activity at Astera Labs
In related news, CFO Michael Truett Tate sold 12,001 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the transaction, the chief financial officer directly owned 192,083 shares of the company’s stock, valued at approximately $23,781,796.23. This trade represents a 5.88% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Jitendra Mohan sold 157,500 shares of the firm’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00. Following the transaction, the chief executive officer directly owned 4,531,732 shares in the company, valued at approximately $596,285,296.56. This represents a 3.36% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 701,042 shares of company stock worth $88,018,149 in the last quarter. 12.50% of the stock is owned by company insiders.
Hedge Funds Weigh In On Astera Labs
A number of large investors have recently bought and sold shares of the stock. BI Asset Management Fondsmaeglerselskab A S purchased a new position in Astera Labs in the 1st quarter worth approximately $1,065,000. Diversified Trust Co increased its stake in Astera Labs by 62.8% in the 1st quarter. Diversified Trust Co now owns 4,369 shares of the company’s stock worth $479,000 after purchasing an additional 1,685 shares during the period. Hsbc Holdings PLC increased its stake in Astera Labs by 128.5% in the 4th quarter. Hsbc Holdings PLC now owns 83,721 shares of the company’s stock worth $14,126,000 after purchasing an additional 47,081 shares during the period. Spear Advisors LLC purchased a new position in Astera Labs in the 4th quarter worth approximately $15,787,000. Finally, Gunpowder Capital Management LLC dba Oliver Wealth Management purchased a new position in Astera Labs in the 4th quarter worth approximately $75,000. 60.47% of the stock is owned by hedge funds and other institutional investors.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.